Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands.
Department of Rheumatology, Erasmus MC, Rotterdam, The Netherlands
RMD Open. 2024 Oct 18;10(4):e004687. doi: 10.1136/rmdopen-2024-004687.
To investigate whether a combination of general health (Visual Analogue Scale (VAS)), Health Assessment Questionnaire-Disability Index (HAQ-DI), pain (VAS/Numerical Rating Scale (NRS)), quality of life (EQ-5D), fatigue (VAS/NRS) and presenteeism (0%-100% productivity loss) could aid as a screening tool to detect active disease in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
RA patients from the tREACH trial and TARA trial (n=683) and PsA patients from the DEPAR cohort (n=525) were included. The association of a deterioration in the aforementioned patient-reported outcome measure (PROM) scores between two consecutive visits and having active disease was assessed. Active disease was defined as a change from disease activity score (DAS) ≤2.4 to DAS >2.4 in RA or Disease Activity Index in Psoriatic Arthritis (DAPSA) ≤14 to DAPSA >14 in PsA. The area under the curve (AUC) of the sum score of deteriorated PROMs was evaluated.
4594 RA and 1154 PsA visits were evaluated and active disease occurred in 358 (8%) RA and 177 (15%) PsA visits. In both RA and PsA, a deterioration in general health (VAS), HAQ-DI, EQ-5D and pain (VAS/NRS) was significantly associated with active disease. The combination of these PROMs showed acceptable to excellent discriminative ability (RA AUC=0.76, PsA AUC=0.85). If a cut-point of ≥1 deteriorated PROMs is used, 40% of the visits in which RA patients have remission or low disease activity are correctly specified (specificity of 40%), while 10% of visits with active disease are overlooked (sensitivity of 90%). In PsA, these percentages are 41% and 4%, respectively.
A combination of general health, HAQ-DI, EQ-5D and pain could aid as a screening tool for active disease in patients with RA and PsA. These data could help facilitate remote monitoring of RA and PsA patients in the future.
ISRCTN26791028, NTR2754.
探讨一般健康状况(视觉模拟评分(VAS))、健康评估问卷残疾指数(HAQ-DI)、疼痛(VAS/数字评定量表(NRS))、生活质量(EQ-5D)、疲劳(VAS/NRS)和工作效率(0%-100%生产力损失)的综合评分是否可作为一种筛查工具,以检测类风湿关节炎(RA)和银屑病关节炎(PsA)患者的活动性疾病。
纳入了 tREACH 试验和 TARA 试验中的 RA 患者(n=683)和 DEPAR 队列中的 PsA 患者(n=525)。评估了上述患者报告结局测量(PROM)评分在两次连续就诊之间恶化与活动性疾病之间的关联。活动性疾病定义为 RA 从疾病活动评分(DAS)≤2.4 变为 DAS>2.4 或 PsA 从银屑病关节炎疾病活动指数(DAPSA)≤14 变为 DAPSA>14。评估了恶化的 PROM 综合评分的曲线下面积(AUC)。
评估了 4594 次 RA 和 1154 次 PsA 就诊,358 次(8%)RA 和 177 次(15%)PsA 就诊出现活动性疾病。在 RA 和 PsA 中,一般健康状况(VAS)、HAQ-DI、EQ-5D 和疼痛(VAS/NRS)的恶化均与活动性疾病显著相关。这些 PROM 的组合具有可接受至极好的区分能力(RA AUC=0.76,PsA AUC=0.85)。如果使用≥1 个恶化的 PROMs 的切点,则 RA 患者缓解或低疾病活动的就诊中有 40%可被正确指定(特异性为 40%),而活动性疾病的就诊中有 10%被漏诊(敏感性为 90%)。在 PsA 中,这些百分比分别为 41%和 4%。
一般健康状况、HAQ-DI、EQ-5D 和疼痛的综合评分可作为 RA 和 PsA 患者活动性疾病的筛查工具。这些数据可能有助于未来方便 RA 和 PsA 患者的远程监测。
ISRCTN26791028,NTR2754。